{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T02:42:22Z","timestamp":1794364942554,"version":"4.9.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jdin.2023.06.014","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T12:05:47Z","timestamp":1689077147000},"page":"17-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States and factors predictive of outcome"],"prefix":"10.1016","volume":"13","author":[{"given":"Paul","family":"Wasuwanich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M.","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teja S.","family":"Chakrala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Motaparthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jdin.2023.06.014_bib1","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.autrev.2008.06.004","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"Borchers","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.jdin.2023.06.014_bib2","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/CCM.0b013e31821201ed","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review","volume":"39","author":"Gerull","year":"2011","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.jdin.2023.06.014_bib3","first-page":"142","article-title":"Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy","volume":"7","author":"Mockenhaupt","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"issue":"8","key":"10.1016\/j.jdin.2023.06.014_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s40629-019-00111-8","article-title":"Severe skin reactions: clinical picture, epidemiology, etiology, pathogenesis, and treatment","volume":"28","author":"Paulmann","year":"2019","journal-title":"Allergo J Int"},{"issue":"7","key":"10.1016\/j.jdin.2023.06.014_bib5","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jid.2016.03.023","article-title":"Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States adults","volume":"136","author":"Hsu","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"9","key":"10.1016\/j.jdin.2023.06.014_bib6","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3390\/medicina57090895","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management","volume":"57","author":"Frantz","year":"2021","journal-title":"Medicina (B Aires)"},{"issue":"2","key":"10.1016\/j.jdin.2023.06.014_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"A severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdin.2023.06.014_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.939210","article-title":"Chronic kidney disease is potentially an independent prognostic factor for death in Stevens-Johnson syndrome and toxic epidermal necrolysis patients","volume":"9","author":"Rattanakaemakorn","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.jdin.2023.06.014_bib9","series-title":"Healthcare Cost and Utilization Project (HCUP). 2010-2011","author":"HCUP Nationwide Inpatient Sample","year":"2019"},{"key":"10.1016\/j.jdin.2023.06.014_bib10","series-title":"Healthcare Cost and Utilization Project (HCUP). 2012-2014","author":"HCUP National Inpatient Sample","year":"2019"},{"issue":"7","key":"10.1016\/j.jdin.2023.06.014_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/pds.3778","article-title":"Identification of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in electronic health record databases","volume":"24","author":"Davis","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jdin.2023.06.014_bib12","unstructured":"Mockenhaupt M, Roujeau J-C. Epidermal necrolysis (Stevens- Johnson syndrome and toxic epidermal necrolysis). In: Kang S, Amagai M, Bruckner AL, et al., eds. Fitzpatrick\u2019s Dermatology. Vol 1. 9th ed. McGraw Hill; 2019:733-748."},{"issue":"4","key":"10.1016\/j.jdin.2023.06.014_bib13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/jamadermatol.2018.5605","article-title":"Development and validation of a risk prediction model for in-hospital mortality among patients with Stevens-Johnson syndrome\/toxic epidermal necrolysis\u2014ABCD-10","volume":"155","author":"Noe","year":"2019","journal-title":"JAMA Dermatology"},{"key":"10.1016\/j.jdin.2023.06.014_bib14","series-title":"Physiology, Urea Cycle","author":"Barmore","year":"2018"},{"issue":"4","key":"10.1016\/j.jdin.2023.06.014_bib15","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jaad.2021.03.088","article-title":"Representation and misdiagnosis of dark skin in a large-scale visual diagnostic challenge","volume":"86","author":"Diao","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2023.06.014_bib16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2133.2011.10705.x","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature","volume":"166","author":"Ziemer","year":"2012","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2023.06.014_bib17","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jid.2017.01.031","article-title":"The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UK","volume":"137","author":"Frey","year":"2017","journal-title":"J Invest Dermatol"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328723001062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328723001062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:00:39Z","timestamp":1762981239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328723001062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":17,"alternative-id":["S2666328723001062"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2023.06.014","relation":{},"ISSN":["2666-3287"],"issn-type":[{"value":"2666-3287","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States and factors predictive of outcome","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2023.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}